Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.

Journal of the neurological sciences - 15 May 2004

Saiki Shinji, Hirose Genjiro, Sakai Koichiro, Kataoka Satoshi, Hori Ariyuki, Saiki Misuzu, Kaito Muichi, Higashi Kotaro, Taki Suzuka, Kakeshita Kazuo, Fujino Susumu, Miaki Miho

Abstract excerpt

OBJECTIVE: Cardiac (123)I-metaiodobenzylguanidine (MIBG) scintigraphy studies of patients with idiopathic Parkinson's disease (PD) found decreased uptake. Whether this decrease is associated with clinical severity as assessed by the Unified Parkinson's Disease Rating Scale (UPDRS) and the phenotypes of PD has not been determined. METHODS: Cardiac MIBG scintigraphy was performed on 34 patients with PD, 7 with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Heart
Share to Iodine Radioisotopes

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lewy Body Disease

Share to Multiple System Atrophy

Share to Neurologic Examination

Share to Radionuclide Imaging

Share to Statistics, Nonparametric

Share to Tremor

Source

Identifiers

PMID: 15140615
DOI: 10.1016/j.jns.2004.02.018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.PMID 15140615Read ↗

Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations.Semantic proximity Read ↗

Cardiac sympathetic denervation in bradykinesia-dominant Parkinson's disease.Semantic proximity Read ↗

Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease.Semantic proximity Read ↗

Comparison of disease progression between brain-predominant Parkinson's disease versus Parkinson's disease with body-involvement phenotypes.Semantic proximity Read ↗

Dual-phase 18 F-FP-CIT positron emission tomography and cardiac 123 I-MIBG scintigraphy of Parkinson's disease patients with GBA mutations: evidence of the body-first type?Semantic proximity Read ↗

Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease.Semantic proximity Read ↗

Relationship between clinical phenotypes and cognitive impairment in Parkinson's disease (PD).Semantic proximity Read ↗

Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study.Semantic proximity Read ↗

Clinical phenotype of subjects with Parkinson's disease and orthostatic hypotension: autonomic symptom and demographic comparison.Semantic proximity Read ↗

Combined Use of 123i-fp-cit Spect and 123i-mibg Scintigraphy for Differentiation of Progressive Supranuclear Palsy Subtypes and Parkinson's DiseaseSemantic proximity Read ↗

Non-motor symptoms and cardiac innervation in SYNJ1-related parkinsonism.Semantic proximity Read ↗

Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.